Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Annals of Neurology, vol.47, issue.6, pp.707-717, 2000. ,
Multiple sclerosis, The Lancet, vol.372, issue.9648, pp.1502-1517, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00996686
T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis, Brain, vol.133, issue.6, pp.1622-1636, 2010. ,
Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein, Nature, vol.292, issue.5818, pp.60-61, 1981. ,
Lessons from multiple sclerosis: models, concepts, observations, Annals of the Rheumatic Diseases, vol.67, pp.56-60, 2008. ,
The origin and application of experimental autoimmune encephalomyelitis, Nature Reviews Immunology, vol.7, issue.11, pp.904-912, 2007. ,
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients, Clinical Immunology, vol.144, issue.2, pp.117-126, 2012. ,
B cells and antibodies in multiple sclerosis pathogenesis and therapy, Nature Reviews Neurology, vol.8, issue.11, pp.613-623, 2012. ,
The spectrum of MOG autoantibody-associated demyelinating diseases, Nature Reviews Neurology, vol.9, issue.8, pp.455-461, 2013. ,
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis, The New England Journal of Medicine, vol.358, issue.7, pp.676-688, 2008. ,
A single dose of rituximab does not deplete b cells in secondary lymphoid organs but alters phenotype and function, American Journal of Transplantation, vol.13, issue.6, pp.1503-1511, 2013. ,
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4 ,
cell proliferation and IFN-production in response to myelin basic protein and myelin oligodendrocyte glycoprotein, European Journal of Immunology, vol.40, issue.10, pp.2942-2956, 2010. ,
Immune regulatory function of B cells, Annual Review of Immunology, vol.30, pp.221-241, 2012. ,
B cells regulate autoimmunity by provision of IL-10, Nature Immunology, vol.3, issue.10, pp.944-950, 2002. ,
Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile, The American Journal of Transplantation, vol.11, issue.3, pp.429-438, 2011. ,
Unique B cell differentiation profile in tolerant kidney transplant patients, The American Journal of Transplantation, vol.14, issue.1, pp.144-155, 2014. ,
DOI : 10.1111/ajt.12508
URL : https://hal.archives-ouvertes.fr/hal-00974748
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission, Journal of Neuroimmunology, vol.239, issue.1-2, pp.80-86, 2011. ,
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, issue.2, pp.530-541, 2011. ,
Predominant autoantibody production by early human B cell precursors, Science, vol.301, issue.5638, pp.1374-1377, 2003. ,
DOI : 10.1126/science.1086907
B-cell tolerance checkpoints in health and autoimmunity, Current Opinion in Immunology, vol.20, issue.6, pp.632-638, 2008. ,
Characterization of antigen-specific B cells using nominal antigen-coated flowbeads, Article ID e84273, vol.8, issue.12, 2013. ,
Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class IIbinding CD4 cells in patients with multiple sclerosis, Journal of Immunology, vol.187, issue.2, pp.1039-1046, 2011. ,
Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria, Annals of Neurology, vol.58, issue.6, pp.840-846, 2005. ,
Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents, Journal of Immunology, vol.181, issue.2, pp.1255-1263, 2008. ,
Blood-brain barrier-specific properties of a human adult brain endothelial cell line, The FASEB Journal, vol.19, issue.13, pp.1872-1874, 2005. ,
Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line, Journal of Leukocyte Biology, vol.86, issue.5, pp.1049-1063, 2009. ,
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases, Clinical Immunology, vol.138, issue.3, pp.247-254, 2011. ,
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice, Journal of Experimental Medicine, vol.188, issue.1, pp.169-180, 1998. ,
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?, Expert Opinion on Therapeutic Targets, vol.16, issue.5, pp.451-462, 2012. ,
Duration of humoral immunity to common viral and vaccine antigens, The New England Journal of Medicine, vol.357, issue.19, pp.1903-1915, 2007. ,
Human immunoglobulin (Ig)M + IgD + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells, The Journal of Experimental Medicine, vol.188, issue.9, pp.1679-1689, 1998. ,
CD40 and autoimmunity: the dark side of a great activator, Seminars in Immunology, vol.21, issue.5, pp.293-300, 2009. ,
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation, International Journal of Cancer, vol.31, issue.1, pp.13-20, 1983. ,
Determinants of human B cell migration across brain endothelial cells, Journal of Immunology, vol.170, issue.9, pp.4497-4505, 2003. ,
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI, Neurology, vol.73, issue.1, pp.32-38, 2009. ,
Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis, The Journal of the American Medical Association, vol.293, issue.20, pp.2496-2500, 2005. ,
T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system, European Journal of Immunology, vol.23, issue.6, pp.1364-1372, 1993. ,
Biology of oligodendrocyte and myelin in the mammalian central nervous system, Physiological Reviews, vol.81, issue.2, pp.871-927, 2001. ,
Frontline: epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination, European Journal of Immunology, vol.34, issue.8, pp.2072-2083, 2004. ,
Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: Frequency, stability and clinicopathologic correlations, Multiple Sclerosis Journal, vol.13, issue.1, pp.7-16, 2007. ,
The role of environmental factors in the pathogenesis of non-organspecific autoimmune diseases, Best Practice and Research, vol.26, issue.1, pp.5-11, 2012. ,
Rheumatoid arthritis and periodontitisinflammatory and infectious connections, Journal of Oral Microbiology, vol.4, 2012. ,
High in vitro immune reactivity to Escherichia coli in neuromyelitis optica patients is correlated with both neurological disabilities and elevated plasma lipopolysaccharide levels, Human Immunology, vol.74, issue.9, pp.1080-1087, 2013. ,
Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?, Tissue Antigens, vol.79, issue.5, pp.315-325, 2012. ,
Human B1 cell frequency: isolation and analysis of human B1 cells, Frontiers in Immunology, vol.3, p.122, 2012. ,
The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis, Journal of Neuroimmunology, vol.262, issue.1-2, pp.92-99, 2013. ,
Specific peripheral B cell tolerance defects in patients with multiple sclerosis, Journal of Clinical Investigation, vol.123, issue.6, pp.2737-2741, 2013. ,
Identification of a B cell-dependent subpopulation of multiple sclerosis by measurements of brain-reactive B cells in the blood, Clinical Immunology, vol.152, issue.1-2, pp.20-24, 2014. ,
Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients, Journal of the Neurological Sciences, vol.211, issue.1-2, pp.67-73, 2003. ,
B cell exchange across the blood-brain barrier in multiple sclerosis, Journal of Clinical Investigation, vol.122, issue.12, pp.4533-4543, 2012. ,
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis, Science Translational Medicine, vol.6, issue.248, pp.248-106, 2014. ,
Compartmentalization of TCR repertoire alteration during rejection of an intrabrain xenograft, Experimental Neurology, vol.192, issue.2, pp.373-383, 2005. ,
A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid, Science Translational Medicine, vol.4, issue.147, 2012. ,
Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer, Journal of Translational Medicine, vol.11, issue.1, p.107, 2013. ,
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies, Journal of Experimental Medicine, vol.210, issue.13, pp.2921-2937, 2013. ,
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases, Nature, vol.507, issue.7492, pp.366-370, 2014. ,